Last edition
News about "Rogers Yongqing Luo"
Everest Medicines to Invest USD 30.9 Million in I-MAB
Everest Medicines has announced a strategic equity investment of USD 30.9 million in US-based biotech firm I-Mab, strengthening its position in next-generation oncology and enhancing synergies across global markets.
Rogers Yongqing Luo | 04/08/2025 | By Mrinmoy Dey
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members